Starting a Cannabis Business in Poland

Licensing
Required
Foreign Ownership
Allowed
Timeline
6-12 months for pharmaceutical distribution authorization
Business Types
3
Medical Cannabis Import & DistributionPharmaceutical WholesaleCBD Retail

Market Overview

Poland legalized medical cannabis in 2017 and has since developed into one of Central Europe's most promising medical cannabis markets. With a population of 38 million -- the largest in Central and Eastern Europe -- and a growing patient base, Poland offers significant scale for medical cannabis importers and distributors. All medical cannabis is currently imported, as no domestic cultivation licenses have been issued, creating a market dependent on international supply chains. The medical cannabis market in Poland has experienced rapid growth as physician awareness has increased and patient stigma has diminished. Cannabis products are dispensed through pharmacies and prescribed by physicians for a range of conditions. The CBD retail market is also developing, with products available in specialized shops and online. For entrepreneurs, Poland's combination of market size, growth trajectory, and the absence of domestic cultivation creates compelling opportunities in import, distribution, and eventually domestic production if licensing is extended.

Capital Requirements

Moderate to high; pharmaceutical wholesale licenses require significant compliance infrastructure

Application Process

1

Register a Polish legal entity (sp. z o.o. or S.A.) with the National Court Register (KRS) and obtain necessary business permits.

2

Apply to the Chief Pharmaceutical Inspector (GIF) for a pharmaceutical wholesale authorization to handle cannabis-based medicinal products.

3

Obtain an import license from the Chief Pharmaceutical Inspector for specific cannabis product imports, providing supplier documentation, product specifications, and certificates of analysis.

4

Establish GDP-compliant warehousing and distribution infrastructure, including temperature-controlled storage, security systems, and quality management procedures.

5

Build relationships with pharmacies authorized to dispense medical cannabis and establish supply contracts with licensed international producers.

Estimated timeline: 6-12 months for pharmaceutical distribution authorization

Key Regulations

  • •Medical cannabis has been legal since 2017 under amendments to the Pharmaceutical Law, allowing import and pharmacy dispensing of cannabis products.
  • •No domestic cultivation is authorized; all medical cannabis is imported, primarily from Canada, the Netherlands, and other EU producers.
  • •Prescriptions can be issued by any physician, though uptake was initially slow due to stigma and lack of education.
  • •Patient numbers have grown significantly, with Poland becoming one of Central Europe's larger medical cannabis markets.

Opportunities

+

Largest Central European market with 38 million people and rapidly growing patient numbers.

+

No domestic cultivation means import and distribution businesses face limited local production competition.

+

Growing physician acceptance and patient awareness driving increasing prescription volumes.

+

Potential for future domestic cultivation licensing would create significant first-mover opportunities.

Challenges

!

Pharmaceutical regulatory compliance is demanding and the Chief Pharmaceutical Inspector's requirements are strict.

!

Medical cannabis prices remain relatively high for Polish consumers, limiting uptake among price-sensitive patients.

!

Political environment can be unpredictable, with conservative elements occasionally opposing cannabis liberalization.

!

Banking and financial services for cannabis businesses remain difficult to secure in Poland.

Frequently Asked Questions

Can I grow cannabis in Poland?

No, as of 2025, no domestic cannabis cultivation licenses have been issued in Poland. All medical cannabis is imported from international suppliers. Any future domestic cultivation would require new legislation or regulatory changes from the Chief Pharmaceutical Inspector.

How big is the Polish medical cannabis market?

Poland's medical cannabis market has grown rapidly and is one of the largest in Central Europe. With 38 million residents and increasing physician adoption, patient numbers are expected to continue growing significantly, particularly as insurance coverage and product availability improve.

What products can be imported for medical cannabis in Poland?

Poland permits import of dried cannabis flower, cannabis oils and extracts, and other cannabis-based pharmaceutical preparations. All imports require GIF authorization, and products must meet Polish pharmaceutical quality standards with full certificates of analysis.

Related Country Guides

Starting a Cannabis Business in Czech Republic

Starting a cannabis business in the Czech Republic. Medical cannabis distribution, SUKL licensing, CBD retail regulations, and opportunities in Central Europe's most tolerant market.

Starting a Cannabis Business in Germany

Guide to starting a cannabis business in Germany. Learn about cannabis social clubs, medical distribution licenses, cultivation permits, and the CanG regulatory framework.

Starting a Cannabis Business in Ireland

Starting a cannabis or CBD business in Ireland. Medical Cannabis Access Programme (MCAP), HPRA licensing, CBD retail under FSAI regulations, and hemp cultivation opportunities.

Explore More

All European Markets|Europe Overview|Legalization Tracker|Industry Analysis

Disclaimer: This information is for educational purposes only and does not constitute legal, financial, or business advice. Cannabis regulations in Poland are subject to change. Consult with qualified legal and financial professionals familiar with Poland's regulatory framework before starting any cannabis-related business. Cannabismarketcap does not guarantee the accuracy or completeness of any information presented.